Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR3A | P46098 | 2/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.46 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.46 |
| ▸ | HTR3B | O95264 | 1/20 | 0.46 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.46 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.46 |
| ▸ | KDM2B | Q8NHM5 | 1/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.37 |
| ▸ | TUBB | P07437 | 1/20 | 0.37 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.37 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.37 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.37 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3176528 | 0.92 | KDM2B (0.47) | HTR3AADRA2AADRA2BADRA2CSLC6A4 | |
| SCHEMBL6852857 | 0.80 | HTR3A (0.43) | HTR3AADRA2AADRA2BADRA2CSLC6A4 | |
| SCHEMBL6852872 | 0.79 | KDM2B (0.47) | KDM2B | |
| SCHEMBL6851337 | 0.77 | KMT2A (0.47) | HTR3AADRA2AADRA2BADRA2CSLC6A4 | |
| SCHEMBL6853010 | 0.77 | CHRNA7 (0.38) | HTR3AADRA2AADRA2BADRA2CSLC6A4 | |
| SCHEMBL6851005 | 0.75 | HSD11B1 (0.42) | HTR3AADRA2AADRA2BADRA2CSLC6A4 | |
| SCHEMBL6851425 | 0.75 | MGLL (0.42) | HTR3AADRA2AADRA2BADRA2CSLC6A4 | |
| SCHEMBL6850905 | 0.75 | HTR3A (0.48) | HTR3AADRA2AADRA2BADRA2CSLC6A4 | |
| SCHEMBL6853015 | 0.74 | HTR3A (0.42) | HTR3AADRA2AADRA2BADRA2CSLC6A4 | |
| SCHEMBL6852997 | 0.74 | HTR3A (0.42) | HTR3AADRA2AADRA2BADRA2CSLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7652052-B2 | Process for producing ramosetron or its salt | ASTELLAS PHARMA INC. (JP) | 2010-01-26 | — | — | US | claimed |
| US-20090069570-A1 | Novel Process for Producing Ramosetron or Its Salt | ASTELLAS PHARMA INC. (JP) | 2009-03-12 | — | — | US | claimed |
| EP-1870408-A1 | NOVEL PROCESS FOR PRODUCING RAMOSETRON OR ITS SALT | Astellas Pharma Inc. (JP) | 2007-12-26 | — | — | EP | claimed |
| US-7652052-B2 | Process for producing ramosetron or its salt | ASTELLAS PHARMA INC. (JP) | 2010-01-26 | — | — | US | disclosed |
| US-7652052-B2 | Process for producing ramosetron or its salt | ASTELLAS PHARMA INC. (JP) | 2010-01-26 | — | — | US | disclosed |
| US-7652052-B2 | Process for producing ramosetron or its salt | ASTELLAS PHARMA INC. (JP) | 2010-01-26 | — | — | US | disclosed |
| US-20090069570-A1 | Novel Process for Producing Ramosetron or Its Salt | ASTELLAS PHARMA INC. (JP) | 2009-03-12 | — | — | US | disclosed |
| US-20090069570-A1 | Novel Process for Producing Ramosetron or Its Salt | ASTELLAS PHARMA INC. (JP) | 2009-03-12 | — | — | US | disclosed |
| US-20090069570-A1 | Novel Process for Producing Ramosetron or Its Salt | ASTELLAS PHARMA INC. (JP) | 2009-03-12 | — | — | US | disclosed |
| EP-1870408-A1 | NOVEL PROCESS FOR PRODUCING RAMOSETRON OR ITS SALT | Astellas Pharma Inc. (JP) | 2007-12-26 | — | — | EP | disclosed |
| EP-1870408-A1 | NOVEL PROCESS FOR PRODUCING RAMOSETRON OR ITS SALT | Astellas Pharma Inc. (JP) | 2007-12-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069570-A1 | Novel Process for Producing Ramosetron or Its Salt | SI, VIP, HTR1D | HTR3A 101/4885ADRA2A 317/4885ADRA2B 270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.